ATE617T1 - Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays. - Google Patents
Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays.Info
- Publication number
- ATE617T1 ATE617T1 AT79101578T AT79101578T ATE617T1 AT E617 T1 ATE617 T1 AT E617T1 AT 79101578 T AT79101578 T AT 79101578T AT 79101578 T AT79101578 T AT 79101578T AT E617 T1 ATE617 T1 AT E617T1
- Authority
- AT
- Austria
- Prior art keywords
- radioimmunoassays
- steroid
- processes
- production
- application
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title abstract 4
- 238000003127 radioimmunoassay Methods 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/908,294 US4323511A (en) | 1978-05-22 | 1978-05-22 | Steroid derivatives and their use in radioimmunoassays |
| EP79101578A EP0005558B1 (de) | 1978-05-22 | 1979-05-22 | Steroidderivate, Verfahren zu ihrer Herstellung und ihre Anwendung bei Radioimmunoassays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE617T1 true ATE617T1 (de) | 1982-02-15 |
Family
ID=25425538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT79101578T ATE617T1 (de) | 1978-05-22 | 1979-05-22 | Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4323511A (de) |
| EP (1) | EP0005558B1 (de) |
| JP (1) | JPS54151959A (de) |
| AT (1) | ATE617T1 (de) |
| AU (1) | AU523079B2 (de) |
| CA (1) | CA1142915A (de) |
| DE (1) | DE2961949D1 (de) |
| IL (1) | IL57303A0 (de) |
| ZA (1) | ZA791923B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4243608A (en) * | 1979-05-14 | 1981-01-06 | E. R. Squibb & Sons, Inc. | 3-(4-Hydroxyphenyl)pentanedioic acid, monohydrazide, derivatives and analogs |
| FR2537586A1 (fr) * | 1982-12-13 | 1984-06-15 | Roussel Uclaf | Derives estratrieniques radioactifs marques a l'iode, leur procede de preparation et leur application aux dosages radio-immunologiques |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1118409A (en) * | 1977-08-12 | 1982-02-16 | Jack Bernstein | Steroid derivatives and their use in radioimmunoassays |
-
1978
- 1978-05-22 US US05/908,294 patent/US4323511A/en not_active Expired - Lifetime
-
1979
- 1979-04-23 ZA ZA791923A patent/ZA791923B/xx unknown
- 1979-04-24 AU AU46414/79A patent/AU523079B2/en not_active Expired
- 1979-04-25 CA CA000326279A patent/CA1142915A/en not_active Expired
- 1979-05-16 IL IL57303A patent/IL57303A0/xx not_active IP Right Cessation
- 1979-05-22 DE DE7979101578T patent/DE2961949D1/de not_active Expired
- 1979-05-22 JP JP6376879A patent/JPS54151959A/ja active Pending
- 1979-05-22 EP EP79101578A patent/EP0005558B1/de not_active Expired
- 1979-05-22 AT AT79101578T patent/ATE617T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US4323511A (en) | 1982-04-06 |
| EP0005558A1 (de) | 1979-11-28 |
| AU523079B2 (en) | 1982-07-08 |
| DE2961949D1 (en) | 1982-03-11 |
| CA1142915A (en) | 1983-03-15 |
| JPS54151959A (en) | 1979-11-29 |
| AU4641479A (en) | 1979-11-29 |
| ZA791923B (en) | 1980-04-30 |
| EP0005558B1 (de) | 1982-01-27 |
| IL57303A0 (en) | 1979-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE295T1 (de) | Vitamin b12 derivate, verfahren zu deren herstellung und ihre verwendung bei radioimmun-testen. | |
| KR830001868A (ko) | 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법 | |
| IL56288A (en) | 15-deoxy-16-hydroxy-2-decarboxy-2-hydroxymethylprostaglandin derivatives and their preparation | |
| ES508735A0 (es) | "procedimiento para la preparacion de derivados de (2-halogeno-ergolinil)-n',n'-dietilurea". | |
| KR830002722A (ko) | 이미다졸리딘 유도체의 제조방법 | |
| GB2002385A (en) | Steroid hemiesters and their use in radioimmunoassays | |
| GR3005135T3 (de) | ||
| AU523079B2 (en) | Steroid derivatives and their use in radioimmunoassays | |
| SE7704616L (sv) | Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat | |
| SE7713704L (sv) | Propionsyraderivat och sett for framstellning av desamma | |
| PT77208B (de) | Neue thieno-thieno-derivate verfahren zu ihrer herstellung und diese verbindugen enthaltende | |
| KR850004470A (ko) | 유기 화합물의 제조방법 | |
| KR840009282A (ko) | 스티렌 유도체의 제조방법 | |
| KR830005225A (ko) | 데오필린의 피페라진 유도체의 제조방법 | |
| KR850002979A (ko) | 1,2,3-트리티안화합물의 신규 제조방법 | |
| GB2003480A (en) | Digoxigenin derivatives | |
| SE7811761L (sv) | 4,5,6,7-tetrahydroimidazo-(4,5-c),pyridinderivat och forfarande for deras framstellning | |
| ATE44742T1 (de) | Verfahren zur herstellung von ergoline n-methyl- derivaten. | |
| DE3268984D1 (en) | Imidazolylcarboxylic acids, their derivatives and production | |
| KR900003171A (ko) | 방사성요오드화 벤조디아제핀 유도체 | |
| ES460117A1 (es) | Procedimiento para la preparacion de nuevos n-bencil-aminoa-cidos que contienen azufre. | |
| GB1536195A (en) | 3-phenyl-sec-butylamine derivatives | |
| SE7901316L (sv) | Derivat av dehydrocykliciminsyror | |
| ES460297A1 (es) | Un compuesto. | |
| KR870003047A (ko) | 벤조산 유도체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |